Manufacturer's ref.No : (b)(4).No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
This complaint is from a literature source.The following complications were reported in this publication: it was reported that 2 patients underwent catheter ablation of atrial fibrillation and suffered cardiac tamponade.Intervention was not reported.Model and catalog number are not available, but the suspected device is thermocool smarttouch.Other biosense webster devices that were also used in this study: carto 3, lasso, pentray nav, visitag.Non-biosense webster devices that were also used in this study: daig duodeca 2-10-2.Publication details: title: multiple procedure outcomes for nonparoxysmal atrial fibrillation: left atrial posterior wall isolation versus stepwise ablation.Objective: to compare multiple-procedure catheter ablation outcomes of a stepwise approach versus left atrial posterior wall isolation (la pwi) in patients undergoing nonparoxysmal atrial fibrillation (npaf) ablation.Methods: two hundred twenty two consecutive patients with npaf underwent first-time ablation using a contact-force sensing ablation catheter utilizing either a stepwise (group 1, n = 111) or la pwi (group 2, n = 111) approach.The duration of follow-up was 36 months.The primary endpoint was freedom from atrial arrhythmia >30 s.Secondary endpoints were freedom from persistent arrhythmia, repeat ablation, and recurrent arrhythmia after repeat ablation.
|